ÂÜÀòÂÒÂ×

Parth Mangrolia, PhD has a diverse work experience spanning multiple roles and organizations. Parth is currently working as a Senior Scientist in Preclinical Development at Asylia Therapeutics, Inc. since May 2021. Prior to this, they held the same role at ImmunoMet Therapeutics, Inc. from August 2018 to July 2020.

Before transitioning to industry, Parth gained valuable research experience at the University of Wisconsin-Madison. Parth served as a Graduate Research Assistant from August 2013 to July 2018, contributing to various research projects. Additionally, they worked as a Teaching Assistant for a full year from January 2015 to December 2015.

Parth also had the opportunity to intern at Merck as a Graduate Intern in Discovery Pharmaceutical Sciences from June 2017 to August 2017. This provided him with industry exposure and further expanded their skillset.

Furthermore, during their undergraduate years at The University of Texas at Austin, Parth worked as an Undergraduate Research Assistant from November 2011 to April 2013. This early research experience laid the foundation for their future career in scientific research and development.

Overall, Parth Mangrolia, PhD's work experience showcases their commitment to scientific research and their ability to contribute effectively in both academic and industry settings.

Parth Mangrolia, PhD, completed their education in Chemical and Biological Engineering. Parth obtained their Bachelor of Science (BS) degree in Chemical Engineering from The University of Texas at Austin, where they studied from 2009 to 2013. Later, Parth pursued their Doctor of Philosophy (PhD) in Chemical and Biological Engineering at the University of Wisconsin-Madison, where they studied from 2013 to 2018.